Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: William Sullivan, Mike McMullen, Alessandro Borsatti, Rebecca Brandes, and More

Premium

Agilent Technologies recently announced a number of management changes. CEO William Sullivan will step down on March 18, 2015 and will be succeeded by Michael McMullen. McMullen has been named president and COO in connection with the transition. McMullen is also senior vice president and president of the company's Chemical Analysis Group. Sullivan will serve as an adviser to Agilent through its fiscal year ending Oct. 31, 2015, the company said.

Agilent also has appointed Alessandro Borsatti to be its senior director of product marketing and scientific affairs. Borsetti has had various roles at Agilent since joining the company in February 2013. Before that, he was global business director of molecular diagnostics at PerkinElmer.

Rebecca Brandes is Agilent's new global marketing director of molecular pathology. She is a co-founder of Prairie Fire Labs and held various marketing positions at Affymetrix and Asuragen.


Nabsys has named Steve Lombardi president and CEO, and appointed him to its board of directors. Previously, he was CEO of Real Time Genomics, and before that he was CEO of Helicos BioSciences. Lombardi has also served as senior vice president of Affymetrix and vice president of genetic analysis at Applied Biosystems.


Quanterix has named Mark Roskey as vice president and general manager of Applications and Reagents. Roskey is responsible for the development and expansion of applications using the company's Simoa platform. He previously was vice president and GM of PerkinElmer's Life Science and Technology division's American Sales and Service organization. He also formerly held senior commercial and technical positions at Caliper Life Sciences, and he has more than 25 years of experience in the life sciences industries.


CombiMatrix disclosed in a filing with the US Securities and Exchange Commission that Wei Richard Ding has tendered his resignation as a member of the firm's board of directors. It said Ding is pursuing a career opportunity that will relocate him overseas.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.